Search for: "AMGEN MANUFACTURING LIMITED"
Results 21 - 40
of 113
Sorted by Relevance
|
Sort by Date
16 May 2022, 12:16 pm
Written Description: Amgen v. [read post]
24 Feb 2012, 5:52 am
Amgen Inc., 2012 WL 517446 (W.D. [read post]
28 Apr 2019, 8:20 am
There are real difficulties with claim drafting for broad and limited claims:This was dealt with in the Amgen v Sanofi (PCSK 9 antibody) cases. [read post]
8 May 2020, 6:57 pm
Supp. 3d at 346.(...)in Amgen Inc. v. [read post]
28 Jan 2019, 11:22 pm
Ct. 1664, 2017; Amgen v Sandoz, 877 F.3d 1315, Fed. [read post]
23 Apr 2024, 10:28 am
See, Amgen Inc. v. [read post]
25 Jan 2019, 9:57 am
The manufacturer warned users against disabling the limit switch. [read post]
25 Jan 2019, 9:57 am
The manufacturer warned users against disabling the limit switch. [read post]
25 Jan 2019, 9:57 am
The manufacturer warned users against disabling the limit switch. [read post]
12 Aug 2022, 6:48 pm
(quoting Amgen Inc. v. [read post]
29 Mar 2010, 10:10 am
” (HT: Pharma Marketing Blog) Anemia Drugs: Anemia drugs by Johnson & Johnson and Amgen may exacerbate heart problems and survival in kidney patients (HT: FiercePharma) Price-fixing: According to a Bloomberg report, Germany cuts costs of drugs by precluding manufacturers from setting their own prices. [read post]
14 Dec 2021, 9:57 am
Eligibility: American Axle & Manufacturing, Inc. v. [read post]
9 Jun 2023, 8:20 am
Goldsmith for copyrights and Amgen Inc. v. [read post]
2 Jun 2023, 2:14 pm
In my last roundup, I puzzled over the Federal Trade Commission’s (FTC) suit to block Amgen’s acquisition of Horizon Therapeutics. [read post]
6 Oct 2020, 7:55 am
” Because the claim as a whole is a method of treatment claim, the district court did not treat the “produced by …” limitations as product-by-process limitations, but considered it to be “merely source limitations. [read post]
15 Mar 2012, 5:00 am
Amgen Inc., 272 Fed. [read post]
12 Jul 2017, 1:34 pm
This is an important case about whether drugs manufactured by Actavis infringe a European patent of Lilly. [read post]
12 Jul 2017, 7:59 am
Eli Lilly v Actavis UK [2017] UKSC 48This is an important case about whether drugs manufactured by Actavis infringe a European patent of Lilly. [read post]
22 Mar 2016, 4:00 am
Pending pro-patent reform bills in 2016 include limits on post-grant challenges so as to exempt biopharma patents. [read post]
9 Aug 2012, 4:39 am
Amgen manufactured both; Procrit was licensed by Johnson & Johnson. [read post]
